O
OPKO Health
Developing proprietary versions of proteins already approved for medical therapy
At a glance
- Status
- Listed
- Listing
- IPO 2007
- Outcome tier
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Open roles
OPKO Health in the Miami ecosystem
The OPKO Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
187 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where OPKO Health was the backer or acquirer, 2010–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
10 deals across OPKO Health's capital deployment.
Where the deals concentrate by sector, stage, and decade.
OPKO Health's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about OPKO Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See OPKO Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


OPKO Health draws $125M against mazdutide royalties in KKR-linked deal